Š΄υ§Œδ HOME MEMBER ‹ΖΡƒŠƒXƒg ‹³ŽΊ‚Μ•—Œi ‹³ŽΊ‚̍sŽ– •εW LINK ENGLISH








‰ί‹Ž‚Μ‰p•Ά‹ΖΡƒŠƒXƒg
™‚Q‚O‚P‚V”N
™‚Q‚O‚P‚U”N
™‚Q‚O‚P‚T”N
™‚Q‚O‚P‚S”N
™‚Q‚O‚P‚R”N
™‚Q‚O‚P‚Q”N
™‚Q‚O‚P‚P”N
š‚Q‚O‚P‚O”N
™‚Q‚O‚O‚X”N
™‚Q‚O‚O‚W”N
™‚Q‚O‚O‚V”N
™‚Q‚O‚O‚U”N
™‚Q‚O‚O‚T”N
™‚Q‚O‚O‚S”N
™‚Q‚O‚O‚R”N
™‚Q‚O‚O‚Q”N
™‚Q‚O‚O‚P”N
™‚Q‚O‚O‚O”N


‚Q‚O‚P‚O”N
  1. Maeda,N., Muta,H., Oflazoglu,E. and Yoshikai Y. :
    Susceptibility of human T-cell leukemia virus type I-infected cells to humanized anti-CD30 monoclonal antibodies in vitro and in vivo
    Cancer Sci.101:224-30(2010)

  2. Kumabe S., Itsumi M., Yamada H. Yajima T., Matsuguchi T., and Yoshikai Y.:
    Dual specificity phosphatase16 is a negative regulator of JNK activity in T cells.
    Microbiol. Immunol.54:105-11(2010)

  3. Hirose Y., Murosaki S., Fujiki T., Yamamoto Y., Yoshikai Y. and Yamashita M., :
    Teichoic acids on Lactobacillus plantarum cell surfaces induce interleukin-12p40 production
    Microbiol. Immunol.54:143-51(2010)

  4. Gotoh K., Tanaka Y., Nishikimi A., Nakamura R., Yamada H., Maeda N., Ishikawa T., Hoshino K., Uruno T., Cao Q, Higashi S., Kawaguchi Y, Enjoji M, Takayanagi, R., Kaisho T. Yoshikai, Y. and Fukui Y., :
    Selective control of type I IFN induction by the Rac activator DOCK2 during TLR-mediated plasmacytoid dendritic cell activation
    J.Exp.Med. 207:721-30(2010)

  5. Nakamura R., Maeda N., Shibata K. Yamada H., Kase T. and Yoshikai Y.,:
    Interleukin-15 is critical in the pathogenesis of influenza A virus-induced acute lung injury
    J.Virol. 84:5574-82(2010)

  6. Sun X. Yamada H., Shibata K., Muta H., Tani K., Podack E.R. Iwakura Y., and Yoshikai Y. :
    CD30 ligand/CD30 plays a critical role in Th17 differentiation in mice.
    J.Immunol185:2222-30(2010)

  7. Onzuka T, Tomita Y, Okano S, Shimizu I, Yamada H, Yoshikai Y, Tominaga R.:
    Antibody-mediated T-cell reduction or increased levels of chimerism overcome resistance to cyclophosphamide-induced tolerance in NKT-deficient mice
    Scand J Immunol.72:106-17(2010)

  8. Saiwai H, Ohkawa Y, Yamada H, Kumamaru H, Harada A, Okano H, Yokomizo T, Iwamoto Y, Okada S.:
    The LTB4-BLT1 axis mediates neutrophil infiltration and secondary injury in experimental spinal cord injury.
    Am J Pathol.176:2352-66.(2010)

  9. H. Kondoh, S. Okano, K. Yoshida, Y. Yonemitsu, Y. Tomita, Y. Yoshikai, N. Wake@& K. Sueishi.:
    Semi-Allogeneic Dendritic Cells Injected via theIntratumoural Injection Route Show Efficient@Antitumour Effects in Cooperation with Host-Derived@Professional Antigen-Presenting Cells@
    Scand. J. Immunol.@72:476-490(2010)

  10. Takeuchi A, Eto M, Tatsugami K, Yamada H, Oki T, Kiyoshima K, Yoshikai Y, Naito S.:
    Mechanism of Synergistic Antitumor Effect of Sorafenib and Interferon-ƒΏ on Treatment of Renal Cell Carcinoma.
    J Urol.184:2549-56(2010)

  11. Jingushi S, Ohfuji S, Sofue M, Hirota Y, Itoman M, Matsumoto T, Hamada Y, Shindo H, Takatori Y, Yamada H, Yasunaga Y, Ito H, Mori S, Owan I, Fujii G, Ohashi H, Iwamoto Y, Miyanishi K, Iga T, Takahira N, Sugimori T, Sugiyama H, Okano K, Karita T, Ando K, Hamaki T, Hirayama T, Iwata K, Nakasone S, Matsuura M, Mawatari T.:
    Multiinstitutional epidemiological study regarding osteoarthritis of the hip in Japan.
    J Orthop Sci. 15:626-31(2010)

  12. Sun X. Yamada H., Shibata K., Muta H., Tani K., Podack E.R. Iwakura Y. and Yoshikai Y.:
    CD30 ligand is a target for a novel biological therapy against colitis associated with Th17 responses
    J Immunol.185:7671-80(2010)